82962

Glucose, blood, by glucose monitoring device(s) cleared by the FDA for home use; in an emergency department or outpatient clinic for diagnostic purposes

CPT code 82962 describes the quantitative measurement of blood glucose using a point-of-care (POC) glucose monitoring device, which is typically cleared by the FDA for home use. This service is specifically rendered in an emergency department or outpatient clinic setting for diagnostic purposes, rather than routine monitoring in a physician's office or a hospital laboratory setting. The procedure involves obtaining a capillary blood sample (e.g., via fingerstick), applying it to a test strip, and reading the glucose level using the specialized device to facilitate rapid clinical decision-making. This immediate result is crucial for timely diagnosis and management of conditions such as hypoglycemia, hyperglycemia, or in patients presenting with symptoms suggestive of metabolic disturbances requiring urgent assessment.

Clinical Indications

  • Rapid diagnosis or monitoring of hypoglycemia or hyperglycemia in acute care settings such as the emergency department or outpatient clinic.
  • Initial assessment of patients presenting with altered mental status, syncope, seizures, or unexplained weakness where metabolic causes are suspected.
  • Evaluation of patients with known or suspected diabetes who present with acute symptoms requiring immediate glucose level determination (e.g., suspected diabetic ketoacidosis, hyperglycemic hyperosmolar state).
  • Screening for glucose abnormalities in individuals with symptoms suggestive of new-onset diabetes or other endocrine disorders.
  • Assessment of glucose levels in patients experiencing acute illness, trauma, or infection where rapid metabolic derangement is a concern.

Procedure Steps

  1. Patient identification and explanation of the procedure, including obtaining informed consent if required.
  2. Aseptic preparation of the skin, typically a finger, using an alcohol wipe.
  3. Performing a capillary puncture, most commonly a fingerstick, to obtain a small blood sample.
  4. Applying the obtained blood sample to a compatible test strip inserted into an FDA-cleared point-of-care glucose monitoring device.
  5. Reading and recording the glucose result displayed by the device.
  6. Proper disposal of sharps (lancet) and contaminated materials (test strip, wipe).
  7. Interpreting the result in the context of the patient's clinical presentation and initiating appropriate management or further diagnostic workup.

Coding Guidelines

  • CPT code 82962 is specifically designated for point-of-care glucose testing using devices cleared by the FDA for home use, when performed in an emergency department or outpatient clinic for diagnostic purposes.
  • This code should not be used for glucose testing performed in a physician's office, which is typically reported with CPT 82948 (Glucose; quantitative, blood (except reagent strip)).
  • It is distinct from glucose testing performed in a hospital's central laboratory using automated analyzers (usually coded with 82947 or 82948).
  • The medical record documentation must clearly support the medical necessity for performing the test in the specified setting and for diagnostic reasons.
  • This code generally represents the technical component of the test; professional interpretation is typically inherent to the evaluation and management (E/M) service provided by the treating clinician.
  • Avoid duplicate billing if another, more comprehensive laboratory glucose test is performed on the same date of service, unless medically necessary and clearly documented.

Associated ICD-10 Codes